|
|
 |
SENSEX
|
 |
-232.85
|
-0.95%
|
24363.30
|
|
|
NIFTY
|
 |
-765.47
|
-0.95%
|
79857.79
|
|
|
Nasdaq
|
 |
207.32
|
0.98%
|
21450.02
|
|
|
Nikkei 225
|
 |
761.33
|
1.85%
|
41820.48
|
|
|
FTSE 100
|
 |
-5.10
|
-0.06%
|
9095.70
|
|
|
 |
|
|
|
|
|
YOU ARE ON
Equity
|
|
|
|
|
|
|
|
|
Industry : Pharmaceuticals & Drugs |
House : Private |
BSE Code |
540222
|
ISIN Demat |
INE947Q01028
|
Book Value (Rs) |
86.99
|
|
NSE Code |
LAURUSLABS
|
Dividend Yield % |
0.15
|
Market Cap (Rs) |
443250.22
|
|
TTM PE(x) |
86.99
|
TTM EPS(Rs) |
9.44
|
Face Value(Rs.) |
2
|
|
|
|
|
|
|
Incorporation Year
|
19-09 2005
|
Registered Office
|
Laurus Enclave, Plot Office 01,Edulapaka Bonangi Village, Parawada,Mandal, Anakapalli, Vishakhapatnam, Andhra Pradesh-531021 .
|
ISINNO
|
INE947Q01028
|
Phone
|
0891 6821101 / 1102
|
E-mail
|
info@lauruslabs.com |
URL
|
www.lauruslabs.com |
Industry
|
Pharmaceuticals & Drugs
|
Chairman
|
Ravindranath Kancherla
|
Managing Director
|
|
Company Secretary
|
G Venkateswar Reddy
|
Listing
|
BSE,NSE
|
|
|
|
|
|
|
|
|
|
|
|